Cigarette smoking during pregnancy is a major public health concern. While there are well-described consequences in early child development, there is very little known about the effects of maternal smoking on human cortical biology during prenatal life. We therefore performed a genome-wide differential gene expression analysis using RNA sequencing (RNA-seq) on prenatal (N = 33; 16 smoking-exposed) as well as adult (N = 207; 57 active smokers) human postmortem prefrontal cortices. Smoking exposure during the prenatal period was directly associated with differential expression of 14 genes; in contrast, during adulthood, despite a much larger sample size, only two genes showed significant differential expression (FDR < 10%). Moreover, 1,315 genes showed significantly different exposure effects between maternal smoking during pregnancy and direct exposure in adulthood (FDR < 10%)-these differences were largely driven by prenatal differences that were enriched for pathways previously implicated in addiction and synaptic function. Furthermore, prenatal and age-dependent differentially expressed genes were enriched for genes implicated in non-syndromic autism spectrum disorder (ASD) and were differentially expressed as a set between patients with ASD and controls in postmortem cortical regions. These results underscore the enhanced sensitivity to the biological effect of smoking exposure in the developing brain and offer insight into how maternal smoking during pregnancy affects gene expression in the prenatal human cortex. They also begin to address the relationship between in utero exposure to smoking and the heightened risks for the subsequent development of neuropsychiatric disorders.
Introduction
Cigarette smoking and nicotine addiction continue to be major public health problems due to their established association with increased risk of cancer, respiratory disease, and many other disease outcomes in adults [1] . Cigarette smoking exposure also is highly deleterious to fetal development, having been associated with heightened risk of intrauterine growth restriction, low birth weight, stillbirth, and mortality [2] [3] [4] [5] [6] [7] . Despite these adverse health outcomes for the smoker and the fetus carried by mothers who smoke, 8.4% of pregnant women continue to smoke while pregnant in the United States [8] . Accumulating evidence suggests that in utero exposure to nicotine and other elements of cigarette smoking are associated with a greater risk of the subsequent development of mental illnesses [3, 9] . Components of cigarette smoke, including nicotine, have neuroteratogenic effects [10] , and there is mixed epidemiological evidence for maternal smoking during pregnancy as a risk factor for neuropsychiatric disorders, including schizophrenia [3, 9] , attention deficit/ hyperactivity disorder [11] [12] [13] [14] [15] , Tourette syndrome [15, 16] , impaired cognitive development [17, 18] , obsessive-compulsive disorder [15] , and autism spectrum disorder (ASD) [19] . Despite the potential ramifications of maternal smoking on the mental health of exposed offspring, little is known about the biological effects of smoke exposure on the developing human brain.
Possible molecular mechanisms underlying risk for neuropsychiatric disease from maternal smoking during pregnancy remain elusive. Previous studies have found epigenetic changes in cord blood [20, 21] and differential gene expression in placental tissue [22] . However, only one prior study has directly examined the associations of maternal smoking during pregnancy with epigenetic changes in the prenatal human brain [23] , and no study, to our knowledge, has characterized transcriptional changes in the prenatal brain. Characterizing the gene regulatory changes associated with smoking exposure in prenatal life may identify potential mechanisms related to disease risks later in life, especially with regard to neuropsychiatric disorders. We can better understand the link between maternal smoking during pregnancy and future behavioral and cognitive sequelae by directly studying molecular changes in prenatal human cortical tissue exposed to cigarette smoke.
To characterize the molecular changes in the developing prenatal brain associated with in utero smoking exposure, we first analyzed the RNA-seq data from postmortem fetal human prefrontal cortex tissue, contrasting the exposed to unexposed prenatal tissue. Then to assess the developmental specificity of these molecular changes in the prenatal cortex, we did an analogous comparison of cortical gene expression between adult smokers and non-smokers. Lastly, to ascertain the potentially age-dependent effects of smoking exposure on the cortex, we formally tested whether the effects of smoking exposure on gene expression were different on the developing brain compared with the adult brain. The results of these investigations highlight the dysregulation of the developing prenatal cortex's transcriptome associated with in utero smoking exposure and their implications for possible mechanisms of risk for neurodevelopmental disorders (NDDs) later in life.
Results
Gene expression changes associated with smoking exposure in the developing brain
We performed differential expression analysis of genes and their transcript features by comparing dorsolateral prefrontal cortex (DLPFC) tissue from 16 smoking-exposed compared with 17 smoking-unexposed prenatal samples (Table 1 , for further details see Results S1 and Supplementary Table S1 ). After correcting for multiple testing (at false discovery rate, FDR < 10%), 14 prenatal genes had evidence of differential expression (DE), mostly at the gene-level summarization ( Table 2 , median absolute log 2 fold change [LFC] = 0.618). Some of these differentially expressed genes are potentially related to nicotine dependence or addiction more broadly: KCNN2, GABRA4, and NRCAM ( Fig. 1a -c) [66] [67] [68] . The most significant differentially expressed transcript feature at the gene level was KCNN2, which encodes a smallconductance Ca 2+ -activated K + channel ( Fig. 1a , p = 2.60 × 10 -6 , LFC = −0.694). GABRA4, a gene coding for the alpha-4 subunit of the GABA receptor, was also differentially expressed ( Fig. 1b , p = 1.86 × 10 -5 , LFC = 1.06). NRCAM, a gene encoding the neuronal cell-adhesion molecule, was differentially expressed at the gene level ( Fig. 1c , p = 7.17 × 10 -5 , LFC = −0.568), and six previously annotated NRCAM exon-exon splice junctions were also differentially expressed (p min = 2.29 × 10 -7 , LFC p-min = −0.689, Supplementary  Table S2 ). Thus, prenatal smoking exposure is associated with changes in the expression of some genes previously associated with addiction in the literature.
Other differentially expressed genes between the exposed and unexposed prenatal groups play a role in neurodevelopment and may be linked to neuropsychiatric disorders: CNTN4, EPHA8, and PCDH10 ( Fig. 1d-f ). Contactin 4 (CNTN4, Fig. 1d , p = 2.79 × 10 -5 , LFC = 0.682) is a cell-adhesion molecule involved in synaptic formation [24] . The association with PCDH10 was in a differentially expressed region ( Fig. 1e , p = 9.45 × 10 -8 , LFC = −1.37, chr4:134,116,962-134,116,976), a 15 basepair strictly intronic region. Protocadherin-10 (PCDH10) encodes a cell-adhesion molecule involved in synaptic elimination [25] . EPH Receptor A8 (EPHA8, Fig. 1f , p = 7.49 × 10 -6 , LFC = 1.55) encodes a member of the Eph family of tyrosine protein kinase receptors, which has a functional role in axonal pathfinding during neurodevelopment [26] . As a sensitivity analysis to further assess confounding by ethnicity (all three prenatal Caucasian samples were smoke-exposed), we undertook a subgroup analysis of the significant differentially expressed genes using only African-American prenatal samples (N = 30). The resulting effect sizes were consistent with those from the original model supporting the robustness of these findings (r = 0.99, p = 1.18 × 10 -10 , Supplementary Fig. S2 ). These findings suggest, perhaps not surprisingly, that genes involved in neurodevelopment may be disrupted by prenatal exposure to cigarette smoke, a putative neurodevelopmental insult. More subtle gene expression changes associated with smoking exposure in the adult brain
In the adult sample, only two genes were differentially expressed between active smoker (N = 57) and non-smoker groups (N = 150; Table 1 ). MARCO, an immune gene, was the most significantly differentially expressed gene among adults ( Fig. 2a ; p = 4.67 × 10 -9 , LFC = −1.603). We used a different cohort of DLPFC tissue from 107 patients with schizophrenia (65 active smokers and 42 non-smokers) to assess the replicability of this differential gene expression in adults. MARCO was similarly differentially expressed in this cohort (p = 3.28 × 10 -5 , LFC = −1.34, Fig. 2b ). To assess the robustness of our model, we then stratified adult smokers into three categories: non-smokers (N = 150), light smokers (N = 23), and heavy smokers (N = 23) based on the cotinine levels (200 ng/mL heavy-light threshold).
Under this ordinal sensitivity model, MARCO remained significantly differentially expressed (p = 6.16 × 10 -10 , LFC = −1.211, Fig. 2c ), and our global results were highly correlated across all transcript feature levels confirming the robustness of our analysis ( Supplementary Fig. S3 ). An exon-exon splice junction mapping to four transcripts of CEP85 (chr1:26,595,127-26,595,950) was also differentially expressed between adult smokers and non-smokers (p = 4.46 × 10 -7 , LFC = −0.25), but this association did not replicate in our independent schizophrenia cohort (p = 0.47, Supplementary Fig. S4 ). Together, these findings indicate that cigarette smoke exposure has subtler effects on the adult prefrontal cortex's transcriptome than on the developing brain, despite having the larger sample size compared with the prenatal cohort.
Significant changes in susceptibility to smoking exposure across development
After observing the non-overlapping genes within the differentially expressed transcript features across the adult and Representative differentially expressed prenatal genes. Normalized expression levels for six genes with significant (FDR < 10%, moderated t-test) differential expression are shown for smoking unexposed (N = 17) and exposed (N = 16) prenatal prefrontal cortex samples. These representative genes have been previously implicated in neurodevelopment and neuropsychiatric disease. RPKM reads per kilobase per million prenatal cohorts associated with smoking exposure, we performed an interaction analysis to more formally determine the potentially age-dependent effects of smoking exposure in prenatal vs adult samples. While the significant main effects of smoking exposure in adulthood were limited to MARCO and CEP85 junction described above, there were 5,293 differentially expressed features corresponding to 1,315 Ensembl genes ( Supplementary Table S3 ) associated with the interaction between developmental stage (pre-vs post-natal) and smoking exposure after adjusting for possible technical and biological confounds (FDR < 10%). Different feature-type analyses offer multiple lines of evidence for genes implicated as interaction genes (i.e., genes that respond differently to cigarette smoking in prenatal vs adult cortical tissue), suggesting that transcript feature-level analysis beyond the gene-level summary offer additional insight into changes in the transcriptomic landscape. For instance, 87 genes were shared as significant interaction genes across all feature types, but 315 genes were solely significant for an interaction effect at the exonlevel summarization (Fig. 3 ). We next asked whether smoking exposure's differential effects on gene expression across the lifespan are mostly Other genes are tagged solely by our feature-level analysis, such as the 56 genes that were only identified as differentially expressed regions and not by other feature-level summarizations driven by significant changes in the prenatal cortical transcriptome, hypothesizing that the prenatal cortical transcriptome is more pliable than the adult one. Post hoc analysis confirmed that more of these transcript features with a significant interaction were nominally differentially expressed (p < 0.05) by smoking exposure in prenatal cortex (N = 1,850, 35.0%) than in adult cortex (N = 585, 11.1%; p = 1.40 × 10 -8 ). These findings underscore that smoking exposure exerts different effects on gene expression across the human lifespan and these effects occur more frequently in the prenatal cortex.
Enrichment of interaction genes in diverse processes and NDDs
To explore the potential functional implications of the 1,315 genes with differential effects of cigarette smoke exposure in prenatal and adult life, we performed gene ontology and pathway analyses with the sets of genes tagged by differentially expressed age-dependent transcript features: genes (N = 752), exons (N = 746), junctions (N = 257), and expressed regions (ERs, N = 285). We uncovered significant enrichment of biological categories across all ontologies tested ( Supplementary Table S4 ).
Here, "nicotine addiction" (hsa04080, p = 2.04 × 10 -7 , q = 3.15 × 10 -5 ) was one of the most significantly enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway categories across multiple feature summarizations. Other top KEGG categories included "retrograde endocannabinoid signaling" (hsa04723, p = 2.04 × 10 -7 , q = 3.15 × 10 -5 ) and "neuroactive ligand-receptor interaction" (hsa05033, p = 2.04 × 10 -7 , q = 3.15 × 10 -5 ). The most significantly enriched biological processes involved "behavior" (GO:0007610, p = 2.33 × 10 -10 , q = 9.87 × 10 -7 ), "positive regulation of nervous system development" (GO:0051962, p = 1.31 × 10 -7 , q = 2.32 × 10 -4 ), and "synapse organization" (GO:0050808, p = 2.84 × 10 -7 , q = 2.57 × 10 -4 ). Interestingly, using disease ontology (DO) enrichment analyses, where pre-defined gene sets are based on prior disease associations in the literature, rather than biological function/pathways, the top enriched disease DO were related to ASD, including gene sets of "autism spectrum disorder" (DOID:0060041, p = 8.45 × 10 -8 , q = 2.57 × 10 -5 ), "autistic disorder" (DOID:12849, p = 8.45 × 10 -8 , q = 2.57 × 10 -5 ), and "pervasive developmental disorder" (DOID:0060040, p = 1.25 × 10 -7 , q = 2.57 × 10 -5 ).
After observing the DO enrichment related to autism and relevant molecular processes, we performed targetedenrichment analyses using publicly available ASD gene databases [27] and previously constructed neurodevelopmental gene sets [28] to better determine sensitivity and specificity of the ASD gene set enrichments. In prenatal samples, this ASD enrichment was driven by IL1RAPL2, GABRA4, CNTN4, NRCAM, and PCDH10 being differentially expressed ( Table 1 , N = 5/14 SFARI genes, p = 3.79 × 10 -4 , Supplementary Table S5A ). We further observed enrichment of significant age-dependent interaction genes across multiple autism gene sets, including SFARI gene (p = 7.20 × 10 -8 ), AutDb (p = 1.17 × 10 -7 ), and curated non-syndromic ASD gene database set (p = 3.77 × 10 -4 , Supplementary Table S5B ). We undertook a parallel analysis of smoking-unexposed cortical samples across the lifespan (prenatal vs adult) to identify neurodevelopmentally regulated genes and contextualize the results (Results S3). We found that gene expression patterning over cortical development is similarly enriched for neuropsychiatric disease gene sets mirroring the enrichment results with age-dependent interaction genes, the greatest enrichment was for ASD gene sets ( Supplementary  Table S5C ). Interaction genes were less significantly enriched for schizophrenia genes implicated from single nucleotide variant (SNV) studies (p = 0.00136) and only nominally significantly enriched for intellectual disability genes (p = 0.0115) and syndromic NDD genes (p = 0.0175; Supplementary Table S5B ). The enriched NDD (N = 6) were a subset of the enriched ASD genes, but the enriched schizophrenia SNV and intellectual disability genes were mostly distinct ( Supplementary Fig. S5 ). Therefore, genes affected differently by cigarette smoke exposure across the lifespan appear enriched in ASD and other neuropsychiatric disorders gene sets.
Smoking exposure's transcriptomic pattern is similar to postmortem brain ASD case-control differences Next, to more fully interrogate these genes in ASD, we performed gene set enrichment analysis in postmortem human brain tissue from a public database of patients with ASD, compared with unaffected controls [29] , by comparing the gene expression differences from our significant differentially expressed prenatal and interaction genes against ASD-related gene expression differences ( Supplementary Table S6 , Supplementary Fig. S6A ). Differentially expressed prenatal genes (N = 14) were more highly ranked relative to other genes in terms of the ASD case-control differences in the frontal cortex (BA9; p = 1.35 × 10 -6 ) and temporal cortex (BA41-42-22; p = 6.49 × 10 -5 ), but not in the vermis (p = 0.646, Supplementary Fig. S6B ). Likewise, the interaction genes tested in this ASD data (N = 1,293) also showed significant enrichment for ASD case-control differences in the frontal cortex (p = 3.45 × 10 -5 ) and temporal cortex (p = 2.77 × 10 -9 ), but not in the vermis (p = 0.963, Supplementary Fig. S6C ). We further found enrichment of these sets of genes among known protein-protein interactions (Results S2, Supplementary  Figure S7 ). We did not observe significant enrichment for the schizophrenia case-control differences [30, 31] with either the differentially expressed prenatal genes (p = 0.14) or the interaction genes (p = 0.23). These findings suggest that molecular changes in the developing human cortex associated with maternal smoking during pregnancy are related at the transcriptomic scale to the cortical pathology of ASD (i.e., these genes are differentially expressed as a group in a comparison of ASD samples to controls from a separate study), and these differences are at least partially selective.
Discussion
This study is the first, to our knowledge, to perform an extensive interrogation of the effect of smoking exposure on the prenatal cortical transcriptome. The prenatal brain is more sensitive to many environmental agents in both human and animal studies than the adult brain [32] [33] [34] . Therefore, one might expect that signatures of smoking exposure would be more pronounced in the developing human brain. Consistent with this hypothesis, we found 14 genes differentially expressed in the prenatal cortex compared to only two genes in the adult cortex. Likewise, developmentally regulated genes were more affected by smoke-exposure during prenatal life than adulthood. The transcriptomic effects of smoking exposure were more noticeable in the prenatal cortex despite the smaller sample size available, underscoring the effects of maternal smoking on the prenatal human brain's sensitive developmental trajectory.
Prenatal exposure was associated with changes in gene expression relevant to neurodevelopment and addiction, which some studies have linked to maternal smoking during pregnancy [35] [36] [37] . NRCAM encodes a neuronal cell-adhesion molecule, and expression was reduced within the smokingexposed prenatal brain. This differential expression may have downstream consequences, as neuronal cell-adhesion molecules are involved in neurodevelopment [38] [39] [40] and have been linked to autism [41] [42] [43] and schizophrenia [44] [45] [46] . KCNN2 levels were also reduced in the smoking-exposed prenatal group. KCNN2 encodes small-conductance Ca 2+activated K + channels and is part of a family of proteins that has been linked to substance abuse [47, 48] .
Smoking exposure was also associated with changes in prenatal expression of multiple genes important in neurodevelopment, such as CNTN4 and EPHA8, as well as components of the GABAergic signaling pathway (Discussion S1). Genes that were differentially expressed by smoking exposure in prenatal but not adult donors and vice versa were preferentially involved in processes relevant to neurodevelopment, such as synapse organization. Consistent with the neurodevelopmental origins of ASD, smoking-associated age-dependent and prenatal genes were enriched in publicly available ASD gene databases and were differentially expressed as a group in an ASD case-control [29] quality-corrected [31] analysis. This intriguing finding was statistically robust and relatively specific to ASD, which may reflect a relatively greater role for disruptions to early brain development in ASD etiology compared with other severe mental illnesses, such as bipolar disorder. Moreover, these enrichment results are consistent with greater enrichment for ASD genes in preferentially prenatal expressed genes compared with other neuropsychiatric disorders [28] , and a parallel analysis likewise indicates that developmentally regulated genes are highly enriched for ASD. Given the limited findings of smoking-associated DE in adults and the fact that adults are the sample population in many ASD studies, we do not believe that this enrichment reflects possible confounding in ASD studies of gene expression in the brain by smoking at the time of death. Furthermore, schizophrenic patients smoke at a much higher rate than the non-psychiatric population-studies of schizophrenia are often more confounded by smoking than ASD studies-but we observed only modest enrichment for schizophrenia genes. Our findings add orthogonal molecular support to the hypothesis that maternal smoking during pregnancy may be a risk factor for neuropsychiatric disease later in life, especially for ASD.
Regardless of age, differentially expressed genes between the smoking-exposed and unexposed donors could also relate to other hazardous chemicals besides nicotine, indirect effects of cigarette smoke exposure, and residual confounding by unmeasured factors associated with smoking. Postmortem brain studies, such as this one, are liable to confounding by various factors (e.g., RNA quality, age, sex, and race), but our exploratory analysis suggests that these confounds are unlikely to be responsible for the gene expression differences. Furthermore, we constructed surrogate variables (SVs) that capture transcriptomic variance driven by hidden confounds and adjusted for these in our analyses, which improved our power to detect differential expression. Cigarette smoke contains over 500 distinct chemicals of which 98 have been deemed dangerous to human health [49] , and the molecular correlates of these compounds in human brain range in characterization. The genes identified in this study as differentially expressed by smoking exposure likely include the ones that predispose to cigarette smoking susceptibility as well as the ones that are altered by smoking or other related exposures. Nonetheless, these differentially expressed genes highlight genes and pathways that represent smoking-related changes in the developing brain.
Our results in DLPFC may not translate to other brain regions, as the effects of cigarette smoke exposure on the developing human cortex may vary across brain regions which have distinct cell type compositions and unique molecular profiles [50] . Moreover, our prenatal cohort includes mostly first trimester prenatal brains, and the effects of smoking-exposure may differ in later prenatal cortical development. Future studies should seek to determine the molecular signature of cigarette smoke exposure across multiple developing brain regions and later time periods to refine the transcriptomic footprint of exposure in the developing human cortex. Finally, the temporality and relative contributions of genes and the environment, particularly the intrauterine environment [51] , on the observed molecular differences deserve further attention. Untangling the extent by which maternal smoking during pregnancy relates to a greater genetic burden for nicotine dependence subsequently inherited by the neonate [52] [53] [54] compared to direct environmental or epigenetic insults [55] warrants further portioning. Here, comprehensive expression quantitative trait loci mapping may help disentangle the functional consequences of predisposing genetic risk for nicotine dependence from the environmental effect of cigarette smoke exposure.
In summary, we performed transcriptome-wide scans to search for disturbances in gene expression associated with in utero smoking exposure and to understand the possible implications of gene dysregulation. The effect of smoking exposure on gene expression was more prominent in the developing prenatal brain than the mature adult brain. Disrupted neurodevelopment due to early environmental insults confers risk for neuropsychiatric disorders later in life, and indeed maternal smoking during pregnancy has been suggested as a risk factor for neuropsychiatric disorders in the affected offspring [3, 9] . Our study provides molecular evidence that maternal smoking during pregnancy may disrupt the pathways relevant in neurodevelopment and potentially influence risk of neuropsychiatric disease in offspring-particularly autism spectrum disorder. Overall, these findings offer new molecular clues into how in utero smoking exposure may disrupt human cortex development and increase the risk for the development of neuropsychiatric disorders in the offspring.
Materials and methods

Sample information
We used a subset of postmortem human brain samples with RNA-sequencing data (N = 240) described in Jaffe el al. [30] to investigate the molecular correlates of smoke exposure across the lifespan. Smoking exposure was determined by nicotine and cotinine levels quantified via LC/MS-MS for the majority of samples (Supplementary Information, SI Appendix).
RNA-sequencing data processing
Four convergent measurements of expression ("feature summarizations") were used to comprehensively assess the transcriptome: gene, exon, exon-exon splice junction, and expressed regions [56] (SI Appendix). We retained the genes, exons, and junctions with at least 10% or more of samples having at least 1 count per million (cpm), and completely unannotated junctions were removed. Expressed regions (ERs) were defined by contiguous sequences with mean library-size normalized coverage > 5 reads per 80 million aligned reads [56] .
Differential expression
Features were tested under an empirical Bayes framework for DE using the moderated t-test implemented in the limma [57] . Surrogate variables (SVs) were constructed using sva [58] and were included as covariates to mitigate latent confounding (Results S4). Tested features with a false discovery rate (FDR) below 10% were considered differentially expressed (DE).
for feature i and donor j and binary smoking exposure Smoke j , adjusting for age, RNA integrity number (RIN), the proportion of reads aligning to chrM (a proxy for RNA quality), gene assignment rate (GAR, a proxy for RNA quality), the first MDS component (ancestry), SVs, and the sex for each donor. A sensitivity analysis was done with adult samples by stratifying the smokers into heavy and light smokers (200 ng/mL cotinine cut point) and testing the ordinal variable for differential expression (non-smoker < light smoker < heavy smoker). Replication, defined as p < 0.05 and same directionality of effect, of DE in adults was assessed using an independent cohort of 107 patients diagnosed with schizophrenia from Jaffe el al. [30] .
Gene set enrichment
For gene set enrichment, the transcript features were mapped to Entrez IDs and subsequently to six different gene ontologies (GO): KEGG [59] , GO-BP [60] , GO-MF [60] , GO-CC [60] , DO [61] , and Reactome [62, 63] . We tested for enrichment in each ontology with the hypergeometric test for overrepresentation implemented in clusterProfiler [64] . Enrichment of DE genes in curated gene sets was tested using Fisher's exact test.
Publically available autism data
We reprocessed the reads from Parikshak et al. [29] and tested for ASD case-control gene expression differences, analogous to our procedure here (SI Appendix). The gen-eSetTest function in limma was used to competitively test whether the sets of genes differentially expressed by smoking exposure were differentially expressed by ASD status, separately by the brain region.
Protein-protein interaction
To create protein-protein interaction (PPI) networks, gene symbols were mapped to unique identifiers in the STRING (v. 10) [65] database (STRING score > 400, homo sapiens). Functional association networks were then constructed on the basis of the corresponding PPI scores.
Code availability
Code is deposited in the Github repository: https://github.
com/LieberInstitute/Smoking_DLPFC_Devel
Data availability
Raw data is available from Synapse.org at accession: doi:10.7303/syn12299750. Processed data (gene, exon, and junction counts) are available at http://eqtl.brainseq.org/pha se1. For additional details, please see Methods and materials in the SI Appendix.
